On 4 December 2020, Ethiopia submitted a Zero Draft resolution to the World Health Organization (WHO) on Strengthening Local Production of Medicines and Other Health Technologies to Improve Access – WHO Resolution on Strengthening Local Production of Medicines and Other… Continue Reading
On March 31, 2020, KEI received a copy of the contract between Johnson & Johnson (“J&J”) and the Department of Health and Human Services (HHS) for the development of J&J’s COVID-19 vaccine.The contract, which is now valued at $1.3 billion,… Continue Reading
KEI has reviewed an exclusive license between the National Institute of Allergy and Infectious Diseases (NIAID) and AbCellera Biologics (“AbCellera”) concerning a technology invented by NIAID that apparently is being used for the Eli Lilly (“Lilly”) antibody treatment for COVID-19… Continue Reading
One of the main objections to march-in rights and reasonable pricing clauses is the repeated assertion by NIH leadership that pharmaceutical companies would never agree to a partnership with the federal government that involves price constraints. This argument defies logic… Continue Reading
On Friday, 22 January 2021, Knowledge Ecology International delivered the following remarks on WHO”s Global Observatory on Health R&D at the 148th session of WHO’s Executive Board. At meetings of WHO governing bodies, non-State actors are limited to one minute… Continue Reading
On 21 January 2021 the People’s Vaccine Alliance and Health Action International (HAI) sent an open letter to Dr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), expressing concern about the lack of political support and reported progress… Continue Reading
On Monday, 11 January 2021, the secretariat of the World Health Organization (WHO) published an 18 page report on the Global strategy and plan of action on public health, innovation and intellectual property (EB148/10). The Director-General’s report contains a detailed… Continue Reading
The contract awarding Sanofi Pasteur (“Sanofi”) 1.8 billion U.S. taxpayers’ dollars for the development and manufacture of a COVID-19 vaccine was posted in the Department of Health and Human Services (HHS) Electronic Reading Room on November 30, 2020. Overall, the… Continue Reading
Today, the last day to SCCR 40, started with the first topic of Agenda Item 8 Other Matters: Copyright in the digital environment See Documents related documents on the meeting page at https://www.wipo.int/meetings/en/details.jsp?meeting_id=56053 The first topic for “other matters”, Copyright… Continue Reading
One of the characteristics we have seen in our analysis of COVID-19 contracts is heterogeneity. The Bayh-Dole was enacted in 1980 to provide for uniform provisions on funding agreements regarding the ownership of inventions and the public’s rights. But for… Continue Reading